Cargando…

Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature

INTRODUCTION: People with non‐severe haemophilia appear to be under‐treated in many countries, and this may lead to joint damage and worsen quality of life. AIM: To review literature for clotting factor replacement prophylaxis in people with non‐severe haemophilia A and B (HA/HB) in relation to long...

Descripción completa

Detalles Bibliográficos
Autores principales: Iorio, Alfonso, Königs, Christoph, Reding, Mark T., Rotellini, Dawn, Skinner, Mark W, Mancuso, Maria Elisa, Berntorp, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091955/
https://www.ncbi.nlm.nih.gov/pubmed/36224704
http://dx.doi.org/10.1111/hae.14676